NCT04072978

Brief Summary

This is a prospective comparative non-randomized cohort study to understand the long-term vision outcomes, safety, and stability of anterior chamber intraocular lenses (AC IOLs) vs. scleral-fixated intraocular lenses (SF IOLs).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

5.3 years

First QC Date

August 26, 2019

Last Update Submit

November 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Endothelial cell loss

    Change in endothelial cell count from baseline compared to 24 months post-operatively.

    Pre-operative (baseline) and 24 weeks post-operatively.

Secondary Outcomes (1)

  • Corrected distance visual acuity (CDVA)

    Pre-operative (baseline), week 1, months 1, 6, 12 and 24 post-operatively.

Other Outcomes (1)

  • Secondary adverse events (SAE's)

    Pre-operative (baseline), week 1, months 1, 6, 12 and 24 post-operatively.

Study Arms (2)

Intraocular lens implantation: AC IOL

Patients who are scheduled to undergo AC IOL (anterior chamber intraocular lens) implantation for any of the following indications: * primary or secondary aphakia * primary or secondary lens subluxation or dislocation

Device: Intraocular lens implantation

Intraocular lens implantation: SF IOL

Patients who are scheduled to undergo SF IOL (scleral fixated intraocular lens) implantation for any of the following indications: * primary or secondary aphakia * primary or secondary lens subluxation or dislocation

Device: Intraocular lens implantation

Interventions

Implantation of an intraocular lens using either an anterior chamber IOL or a scleral fixated IOL using the modified Yamane technique.

Also known as: IOL implantation
Intraocular lens implantation: AC IOLIntraocular lens implantation: SF IOL

Eligibility Criteria

Age16 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who are planned to undergo surgical implantation of an anterior chamber intraocular lens or a scleral-fixated IOL who present to the study investigators as part of the vitreoretinal surgery team at Sunnybrook Hospital or the Toronto Western Hospital.

You may qualify if:

  • Patients who are undergoing AC IOL or SF IOL implantation for any reason (including but not limited to aphakia, posterior capsular rupture, primary or secondary lens dislocation/ subluxation or IOL exchange).
  • Patients on whom imaging (specular microscopy, biometry and OCT) can be performed without delaying their treatment (i.e. based on availability of operator).
  • Decision makers able to provide informed consent.

You may not qualify if:

  • Inability to obtain adequate imaging, in the form of specular microscopy and OCT data at baseline.
  • Patients unable to attend follow-up visits.
  • Patients who have had a corneal transplant prior to secondary IOL implantation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnybrook Hospital

Toronto, Ontario, M4N 3M5, Canada

RECRUITING

Related Publications (6)

  • Chan TC, Lam JK, Jhanji V, Li EY. Comparison of outcomes of primary anterior chamber versus secondary scleral-fixated intraocular lens implantation in complicated cataract surgeries. Am J Ophthalmol. 2015 Feb;159(2):221-6.e2. doi: 10.1016/j.ajo.2014.10.016. Epub 2014 Oct 22.

    PMID: 25448990BACKGROUND
  • Krysik K, Dobrowolski D, Wroblewska-Czajka E, Lyssek-Boron A, Wylegala E. Comparison of the Techniques of Secondary Intraocular Lens Implantation after Penetrating Keratoplasty. J Ophthalmol. 2018 Sep 12;2018:3271017. doi: 10.1155/2018/3271017. eCollection 2018.

    PMID: 30298105BACKGROUND
  • Kwong YY, Yuen HK, Lam RF, Lee VY, Rao SK, Lam DS. Comparison of outcomes of primary scleral-fixated versus primary anterior chamber intraocular lens implantation in complicated cataract surgeries. Ophthalmology. 2007 Jan;114(1):80-5. doi: 10.1016/j.ophtha.2005.11.024. Epub 2006 Oct 27.

    PMID: 17070590BACKGROUND
  • Negretti GS, Lai M, Petrou P, Walker R, Charteris D. Anterior chamber lens implantation in vitrectomised eyes. Eye (Lond). 2018 Mar;32(3):597-601. doi: 10.1038/eye.2017.261. Epub 2017 Dec 8.

    PMID: 29219957BACKGROUND
  • Yamane S, Sato S, Maruyama-Inoue M, Kadonosono K. Flanged Intrascleral Intraocular Lens Fixation with Double-Needle Technique. Ophthalmology. 2017 Aug;124(8):1136-1142. doi: 10.1016/j.ophtha.2017.03.036. Epub 2017 Apr 27.

    PMID: 28457613BACKGROUND
  • Brunin G, Sajjad A, Kim EJ, Montes de Oca I, Weikert MP, Wang L, Koch DD, Al-Mohtaseb Z. Secondary intraocular lens implantation: Complication rates, visual acuity, and refractive outcomes. J Cataract Refract Surg. 2017 Mar;43(3):369-376. doi: 10.1016/j.jcrs.2016.12.024.

    PMID: 28410720BACKGROUND

MeSH Terms

Conditions

Corneal Endothelial Cell Loss

Interventions

Lens Implantation, Intraocular

Condition Hierarchy (Ancestors)

Corneal DiseasesEye DiseasesEye ManifestationsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Peter Kertes, MD

    Sunnybrook Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist - Retina Specialist

Study Record Dates

First Submitted

August 26, 2019

First Posted

August 28, 2019

Study Start

September 1, 2019

Primary Completion

December 30, 2024

Study Completion

January 30, 2025

Last Updated

November 27, 2023

Record last verified: 2023-11

Locations